GENEREX BIOTECHNOLOGY CORPORATION
February 1, 2020
Securities Transfer Corporation
2901 N. Dallas Parkway, Suite 380
Plano, Texas 75093
RE: Transfer Agent Instructions
Ladies and Gentlemen:
We hereby request that you immediately retire three hundred million (300,000,000) shares that we hold in our subsidiary, NuGenerex Immuno-Oncology, Inc.
Very truly yours,
GENEREX BIOTECHNOLOGY CORPORATION
By:/s/ Joeseph Moscato
Name: Joseph Moscato
Title: CEO
